Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
Company address
Science City Road, Lincoln House, Ahmedabad, GJ, 380060
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Lincoln Pharmaceuticals Ltd or scroll over to Lincoln Pharmaceuticals Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Lincoln Pharmaceuticals Ltd?
The share price of Lincoln Pharmaceuticals Ltd stocks is ₹558.30 as on 02/04/2025
What is the Market Cap of Lincoln Pharmaceuticals Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Lincoln Pharmaceuticals Ltd stock is ₹1,118.3 Cr on 02/04/2025.
In which sector / industry does Lincoln Pharmaceuticals Ltd operate?
Lincoln Pharmaceuticals Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.
What was the revenue of Lincoln Pharmaceuticals Ltd?
The revenue of Lincoln Pharmaceuticals Ltd as of 2023 was ₹571.2 Cr
What is the PE ratio of Lincoln Pharmaceuticals Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Lincoln Pharmaceuticals Ltd is
12.52 as on 02/04/2025.
What is the 52 week high price of Lincoln Pharmaceuticals Ltd?
The 52 week high of Lincoln Pharmaceuticals Ltd stock is ₹975.00.
What is the 52 week low price of Lincoln Pharmaceuticals Ltd?
The 52 week low of Lincoln Pharmaceuticals Ltd stock is ₹498.00.
Can fractional shares of Lincoln Pharmaceuticals Ltd be purchased?
No, you cannot buy fractional shares of Lincoln Pharmaceuticals Ltd, or any listed Indian company as of now.